{"id":46058,"date":"2026-04-24T17:02:39","date_gmt":"2026-04-24T15:02:39","guid":{"rendered":"https:\/\/semaxpolska.com\/?p=46058"},"modified":"2026-07-12T12:02:08","modified_gmt":"2026-07-12T10:02:08","slug":"neziaduce-ucinky-medeneho-peptidu-ghk-cu","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/sk\/skutki-uboczne-peptydu-miedzi-ghk-cu\/","title":{"rendered":"Ved\u013eaj\u0161ie \u00fa\u010dinky peptidu medi (GHK-Cu) vo vedeck\u00fdch v\u00fdskumoch"},"content":{"rendered":"<p data-start=\"79\" data-end=\"998\">Zazn\u00e1van\u00e9 ved\u013eaj\u0161ie \u00fa\u010dinky meden\u00e9ho peptidu (GHK-Cu) vo vedeck\u00fdch \u0161t\u00fadi\u00e1ch s\u00fa zvy\u010dajne minim\u00e1lne a naj\u010dastej\u0161ie obmedzen\u00e9 na mierne lok\u00e1lne reakcie. V \u0161t\u00fadi\u00e1ch na \u013eu\u010foch, ktor\u00e9 pou\u017e\u00edvali topick\u00e9 pr\u00edpravky, napr\u00edklad v kontexte starnutia poko\u017eky alebo hojenia r\u00e1n, meden\u00fd peptid zvy\u010dajne dobre tolerovali. Niektor\u00ed \u00fa\u010dastn\u00edci hl\u00e1sili mierne podr\u00e1\u017edenie poko\u017eky, mierne za\u010dervenanie alebo prechodn\u00fa citlivos\u0165 v mieste aplik\u00e1cie (Pickart &amp; Margolina, 2018; Reddy et al., 2012). Tieto pr\u00edznaky s\u00fa zvy\u010dajne kr\u00e1tkodob\u00e9 a pri pokra\u010duj\u00facom pou\u017e\u00edvan\u00ed nevydr\u017eia. V \u0161t\u00fadi\u00e1ch na zvierat\u00e1ch a laborat\u00f3rnych experimentoch sa pri \u0161tandardn\u00fdch experiment\u00e1lnych d\u00e1vkach nepozorovali \u017eiadne konzistentn\u00e9 zn\u00e1mky syst\u00e9movej toxicity. Celkovo sa meden\u00fd peptid \u010dasto opisuje ako zl\u00fa\u010denina s priazniv\u00fdm bezpe\u010dnostn\u00fdm profilom v porovnan\u00ed s in\u00fdmi biologicky akt\u00edvnymi peptidmi.<\/p>\n<p data-start=\"1000\" data-end=\"1907\">Z mechanistick\u00e9ho h\u013eadiska n\u00edzka frekvencia ne\u017eiaducich udalost\u00ed m\u00f4\u017ee vypl\u00fdva\u0165 zo skuto\u010dnosti, \u017ee tento peptid sa prirodzene vyskytuje v \u013eudskom tele. Je pr\u00edtomn\u00fd v telesn\u00fdch tekutin\u00e1ch, ako je krvn\u00e1 plazma a sliny, a v tkaniv\u00e1ch, \u010do zni\u017euje riziko imunitn\u00fdch reakci\u00ed alebo toxicity. Okrem toho meden\u00fd peptid silne via\u017ee me\u010f, \u010do umo\u017e\u0148uje jej kontrolovan\u00e9 dod\u00e1vanie a obmedzuje akumul\u00e1ciu vo\u013enej medi, ktor\u00e1 by mohla sp\u00f4sobi\u0165 oxida\u010dn\u00fd stres. Je v\u0161ak potrebn\u00e9 zd\u00f4razni\u0165, \u017ee v\u00e4\u010d\u0161ina \u00fadajov o bezpe\u010dnosti poch\u00e1dza z lok\u00e1lnych aplik\u00e1ci\u00ed, nie z celkovej expoz\u00edcie. Meden\u00fd peptid pou\u017eit\u00fd v \u0161t\u00fadi\u00e1ch je dostupn\u00fd prostredn\u00edctvom dod\u00e1vate\u013eov, ako je SemaxPolska. \u017diadne z\u00e1va\u017en\u00e9 ne\u017eiaduce udalosti v s\u00fa\u010dasn\u00fdch \u0161t\u00fadi\u00e1ch neznamenaj\u00fa potvrden\u00fa dlhodob\u00fa bezpe\u010dnos\u0165, najm\u00e4 pri vy\u0161\u0161\u00edch d\u00e1vkach alebo celkovej aplik\u00e1cii.<\/p>\n<h2 data-start=\"1914\" data-end=\"2008\"><strong data-start=\"1914\" data-end=\"2008\">Je peptid medi (GHK-Cu) pova\u017eovan\u00fd za bezpe\u010dn\u00fd v klinick\u00fdch \u0161t\u00fadi\u00e1ch u \u013eud\u00ed?<\/strong><\/h2>\n<p data-start=\"2010\" data-end=\"2687\">Me\u010fnat\u00fd peptid je na z\u00e1klade dostupn\u00fdch klinick\u00fdch a kozmetick\u00fdch \u0161t\u00fadi\u00ed, najm\u00e4 pri lok\u00e1lnom pou\u017eit\u00ed, v\u0161eobecne pova\u017eovan\u00fd za bezpe\u010dn\u00fd. Treba v\u0161ak poznamena\u0165, \u017ee komplexn\u00e9 \u00fadaje o bezpe\u010dnosti pri r\u00f4znych sp\u00f4soboch podania s\u00fa st\u00e1le obmedzen\u00e9. Kontrolovan\u00e9 \u0161t\u00fadie na \u013eu\u010foch, vr\u00e1tane \u0161t\u00fadi\u00ed o starnut\u00ed poko\u017eky a hojen\u00ed r\u00e1n, nazna\u010duj\u00fa dobr\u00fa zn\u00e1\u0161anlivos\u0165 a absenciu v\u00e1\u017enych ved\u013eaj\u0161\u00edch \u00fa\u010dinkov. Tieto \u0161t\u00fadie, ktor\u00e9 zah\u0155\u0148ali pravideln\u00e9 pou\u017e\u00edvanie po\u010das nieko\u013ek\u00fdch t\u00fd\u017ed\u0148ov, z\u00e1rove\u0148 preuk\u00e1zali zlep\u0161enie parametrov poko\u017eky (Pickart &amp; Margolina, 2018; Mulder et al., 1994), \u010do nazna\u010duje prijate\u013en\u00fa kr\u00e1tkodob\u00fa bezpe\u010dnos\u0165 pre dermatologick\u00e9 aplik\u00e1cie.<\/p>\n<p data-start=\"2689\" data-end=\"3080\">V\u00e4\u010d\u0161ina \u00fadajov v\u0161ak poch\u00e1dza z kozmetick\u00fdch alebo lok\u00e1lnych aplik\u00e1ci\u00ed. Ch\u00fdbaj\u00fa rozsiahle, dobre navrhnut\u00e9 klinick\u00e9 \u0161t\u00fadie hodnotiace dlhodob\u00e9 pou\u017eitie, syst\u00e9mov\u00e9 podanie alebo \u00fa\u010dinky v r\u00f4znych popul\u00e1ci\u00e1ch. V niektor\u00fdch krajin\u00e1ch je meden\u00fd peptid klasifikovan\u00fd ako kozmetick\u00e1 zlo\u017eka, nie ako liek, \u010do odr\u00e1\u017ea s\u00fa\u010dasn\u00fd stav vedeck\u00fdch d\u00f4kazov.<\/p>\n<p data-start=\"3082\" data-end=\"3567\">Z biologick\u00e9ho h\u013eadiska jeho prirodzen\u00e1 pr\u00edtomnos\u0165 v tele a \u00fa\u010das\u0165 na opravn\u00fdch procesoch podporuj\u00fa jeho bezpe\u010dnostn\u00fd profil. To v\u0161ak nenahr\u00e1dza potrebu \u010fal\u0161\u00edch klinick\u00fdch \u0161t\u00fadi\u00ed. Peptid medi pou\u017e\u00edvan\u00fd v \u0161t\u00fadi\u00e1ch je k dispoz\u00edcii prostredn\u00edctvom dod\u00e1vate\u013eov, ako je SemaxPolska. S\u00fa\u010dasn\u00e9 \u00fadaje nazna\u010duj\u00fa bezpe\u010dnos\u0165 pri lok\u00e1lnom pou\u017eit\u00ed, ale nepotvrdzuj\u00fa pln\u00fa klinick\u00fa bezpe\u010dnos\u0165 pri dlhodobom alebo syst\u00e9movom pou\u017eit\u00ed.<\/p>\n<h2 data-start=\"3574\" data-end=\"3656\"><strong data-start=\"3574\" data-end=\"3656\">Ak\u00e9 toxikologick\u00e9 \u00fadaje o medenom peptide (GHK-Cu) sa nach\u00e1dzaj\u00fa vo vedeckej literat\u00fare?<\/strong><\/h2>\n<p data-start=\"3658\" data-end=\"4341\">Toxikologick\u00e9 \u00fadaje o medenom peptide nazna\u010duj\u00fa n\u00edzku toxicitu v laborat\u00f3rnych (in vitro) aj zvierac\u00edch (in vivo) \u0161t\u00fadi\u00e1ch. \u0160t\u00fadie ukazuj\u00fa, \u017ee meden\u00fd peptid nem\u00e1 negat\u00edvny vplyv na \u017eivotaschopnos\u0165 buniek pri koncentr\u00e1ci\u00e1ch bl\u00edzkych t\u00fdm, ktor\u00e9 sa vyskytuj\u00fa v biologick\u00fdch syst\u00e9moch. Niektor\u00e9 \u0161t\u00fadie dokonca preuk\u00e1zali, \u017ee podporuje bunkov\u00fa opravu a zvy\u0161uje antioxida\u010dn\u00fa aktivitu (Gruchlik et al., 2012). \u0160t\u00fadie na zvierat\u00e1ch zameran\u00e9 na hojenie r\u00e1n, z\u00e1pal a regener\u00e1ciu tkan\u00edv neodhalili po\u0161kodenie org\u00e1nov ani v\u00fdznamn\u00e9 syst\u00e9mov\u00e9 \u00fa\u010dinky pri typick\u00fdch experiment\u00e1lnych d\u00e1vkach (Ma et al., 2020; Park et al., 2016).<\/p>\n<p data-start=\"4343\" data-end=\"4603\">Dodato\u010dn\u00e9 \u0161t\u00fadie o bezpe\u010dnosti poko\u017eky nazna\u010duj\u00fa n\u00edzky potenci\u00e1l podr\u00e1\u017edenia, dokonca aj pri opakovanom lok\u00e1lnom podan\u00ed (Lima &amp; Moraes, 2018). D\u00f4le\u017eit\u00fdm faktorom je aj r\u00fdchly metabolizmus a elimin\u00e1cia z tela, \u010do zni\u017euje riziko akumul\u00e1cie.<\/p>\n<p data-start=\"4605\" data-end=\"5305\">Z mechanistick\u00e9ho h\u013eadiska p\u00f4sob\u00ed meden\u00fd peptid ako regul\u00e1tor biologick\u00fdch procesov, ovplyv\u0148uje g\u00e9nov\u00fa expresiu a oxida\u010dn\u00fa rovnov\u00e1hu, namiesto toho, aby pri vysok\u00fdch koncentr\u00e1ci\u00e1ch vyvol\u00e1val siln\u00fa biologick\u00fa odpove\u010f, ako je to v pr\u00edpade niektor\u00fdch l\u00e1tok. K tomu prispieva jeho n\u00edzka toxicita. Je v\u0161ak d\u00f4le\u017eit\u00e9 zd\u00f4razni\u0165, \u017ee v\u00e4\u010d\u0161ina toxikologick\u00fdch \u00fadajov poch\u00e1dza z predklinick\u00fdch a kr\u00e1tkodob\u00fdch \u0161t\u00fadi\u00ed. Meden\u00fd peptid pou\u017e\u00edvan\u00fd vo v\u00fdskume je dostupn\u00fd u dod\u00e1vate\u013eov, ako je SemaxPolska. S\u00fa\u010dasn\u00e9 \u00fadaje nie s\u00fa dostato\u010dn\u00e9 na ur\u010denie bezpe\u010dn\u00fdch \u00farovn\u00ed expoz\u00edcie pre v\u0161etky met\u00f3dy pou\u017eitia alebo pre dlhodob\u00e9 \u013eudsk\u00e9 pou\u017eitie.<\/p>\n<h2 data-start=\"5312\" data-end=\"5375\"><strong data-start=\"5312\" data-end=\"5375\">Boli v \u0161t\u00fadi\u00e1ch hl\u00e1sen\u00e9 rizik\u00e1 por\u00fach rovnov\u00e1hy medi?<\/strong><\/h2>\n<p data-start=\"5377\" data-end=\"5953\">Potenci\u00e1lne riziko spojen\u00e9 s nerovnov\u00e1hou medi bolo v \u0161t\u00fadi\u00e1ch zoh\u013eadnen\u00e9, av\u0161ak nenach\u00e1dza siln\u00e9 potvrdenie v experiment\u00e1lnych v\u00fdsledkoch pri \u0161tandardn\u00fdch \u00farovniach pou\u017eit\u00fdch v \u0161t\u00fadi\u00e1ch. Me\u010fnat\u00fd peptid (GHK-Cu) silne via\u017ee me\u010f a p\u00f4sob\u00ed ako kontrolovan\u00fd nosi\u010d, \u010do znamen\u00e1, \u017ee ju transportuje v bezpe\u010dnej forme namiesto zvy\u0161ovania hladiny vo\u013en\u00fdch i\u00f3nov medi. Vo\u013en\u00e1 me\u010f m\u00f4\u017ee iniciova\u0165 \u0161kodliv\u00e9 oxida\u010dn\u00e9 reakcie, zatia\u013e \u010do mednat\u00fd peptid toto riziko obmedzuje udr\u017eiavan\u00edm medi v stabilnom a regulovanom stave (Pickart et al., 2015).<\/p>\n<p data-start=\"5955\" data-end=\"6386\">V\u00fdskum oxida\u010dn\u00e9ho stresu nazna\u010duje, \u017ee meden\u00fd peptid m\u00f4\u017ee dokonca zn\u00ed\u017ei\u0165 po\u0161kodenie buniek podporou antioxida\u010dn\u00fdch syst\u00e9mov a regul\u00e1ciou g\u00e9nov s\u00favisiacich s ochranou pred oxida\u010dn\u00fdm stresom (Ma et al., 2020). Existuj\u00fa v\u0161ak teoretick\u00e9 obavy, \u017ee ve\u013emi vysok\u00e9 d\u00e1vky alebo neobvykl\u00e1 akumul\u00e1cia by mohli ovplyvni\u0165 prirodzen\u00fa rovnov\u00e1hu medi v tele, najm\u00e4 v syst\u00e9moch citliv\u00fdch na hladinu kovov.<\/p>\n<p data-start=\"6388\" data-end=\"6786\">Doteraj\u0161ie \u0161t\u00fadie neodhalili jednozna\u010dn\u00e9 pr\u00edpady pred\u00e1vkovania me\u010fou ani v\u00fdznamn\u00e9 nerovnov\u00e1hy spojen\u00e9 s pou\u017eit\u00edm meden\u00fdch peptidov za \u0161tandardn\u00fdch experiment\u00e1lnych alebo kozmetick\u00fdch podmienok. Treba si v\u0161ak uvedomi\u0165, \u017ee v\u00e4\u010d\u0161ina \u0161t\u00fadi\u00ed sa vykon\u00e1va za kontrolovan\u00fdch podmienok, pri relat\u00edvne n\u00edzkych d\u00e1vkach a lok\u00e1lnom podan\u00ed, \u010do obmedzuje mo\u017enos\u0165 zov\u0161eobecnenia v\u00fdsledkov.<\/p>\n<p data-start=\"6788\" data-end=\"7304\" data-is-last-node=\"\" data-is-only-node=\"\">Z mechanistick\u00e9ho h\u013eadiska meden\u00fd peptid pom\u00e1ha udr\u017eiava\u0165 rovnov\u00e1hu medi t\u00fdm, \u017ee p\u00f4sob\u00ed ako regulovan\u00fd transportn\u00fd syst\u00e9m. T\u00e1to rovnov\u00e1ha v\u0161ak z\u00e1vis\u00ed od faktorov, ako je d\u00e1vka, sp\u00f4sob podania a biologick\u00fd kontext. Peptid medi pou\u017e\u00edvan\u00fd vo v\u00fdskume je dostupn\u00fd prostredn\u00edctvom dod\u00e1vate\u013eov, ako je SemaxPolska. Napriek absencii jednozna\u010dn\u00fdch d\u00f4kazov o riziku naru\u0161enia rovnov\u00e1hy medi nie je vplyv dlhodob\u00e9ho alebo vysoko d\u00e1vkovan\u00e9ho syst\u00e9mov\u00e9ho pou\u017eitia plne pochopen\u00fd a vy\u017eaduje si \u010fal\u0161\u00ed v\u00fdskum.<\/p>\n<p>&nbsp;<\/p>\n<h4>Odkazy<\/h4>\n<ul>\n<li data-start=\"103\" data-end=\"294\"><span style=\"font-size: 10pt;\">Pickart, L. &amp; Margolina, A. (2018). Regenerat\u00edvne a ochrann\u00e9 \u00fa\u010dinky peptidu GHK-Cu vo svetle nov\u00fdch g\u00e9nov\u00fdch \u00fadajov. <em data-start=\"233\" data-end=\"282\">International Journal of Molecular Sciences, 19<\/em>(7), 1987.<\/span><\/li>\n<li data-start=\"296\" data-end=\"437\"><span style=\"font-size: 10pt;\">Reddy, B. Y., Jow, T., &amp; Hantash, B. M. (2012). Bioakt\u00edvne oligopeptidy v dermatol\u00f3gii: \u010cas\u0165 I. <em data-start=\"392\" data-end=\"422\">Experiment\u00e1lna dermatol\u00f3gia, 21<\/em>(8), 563\u2013568.<\/span><\/li>\n<li data-start=\"439\" data-end=\"713\"><span style=\"font-size: 10pt;\">Mulder, G. D., Patt, L. M., Sanders, L., Rosenstock, J., Altman, M. I., Hanley, M. E., &amp; Duncan, G. W. (1994). Zlep\u0161en\u00e9 hojenie vredov u pacientov s diabetom pomocou topickej lie\u010dby glycyl-L-histidyl-L-lyz\u00ednom me\u010fnat\u00fdm. <em data-start=\"664\" data-end=\"698\">Oprava a regener\u00e1cia r\u00e1n, 2<\/em>(4), 259\u2013269.<\/span><\/li>\n<li data-start=\"715\" data-end=\"963\"><span style=\"font-size: 10pt;\">Gruchlik, A., Jurzak, M., Chodurek, E., &amp; Dzierzewicz, Z. (2012). \u00da\u010dinok Gly-Gly-His, Gly-His-Lys a ich komplexov s me\u010fou na sekr\u00e9ciu IL-6 z\u00e1visl\u00fa od TNF-\u03b1 v norm\u00e1lnych \u013eudsk\u00fdch derm\u00e1lnych fibroblastoch. <em data-start=\"913\" data-end=\"946\">Acta Poloniae Pharmaceutica, 69<\/em>(6), 1303\u20131309.<\/span><\/li>\n<li data-start=\"965\" data-end=\"1201\"><span style=\"font-size: 10pt;\">Ma, W., Li, M., Ma, H., Li, W., Liu, L., Yin, Y., Zhou, X., &amp; Hou, G. (2020). Ochrann\u00e9 \u00fa\u010dinky GHK-Cu pri p\u013e\u00facnej fibr\u00f3ze indukovanej bleomyc\u00ednom prostredn\u00edctvom antioxida\u010dn\u00e9ho stresu a protiz\u00e1palov\u00fdch dr\u00e1h. <em data-start=\"1170\" data-end=\"1190\">Vedy o \u017eivote, 241<\/em>, 117139.<\/span><\/li>\n<li data-start=\"1203\" data-end=\"1391\"><span style=\"font-size: 10pt;\">Park, J. R., Lee, H., Kim, S. I., &amp; Yang, S. R. (2016). Tripeptidick\u00fd komplex GHK-Cu zmier\u0148uje ak\u00fatne po\u0161kodenie p\u013e\u00fac vyvolan\u00e9 lipopolysacharidom u my\u0161\u00ed. <em data-start=\"1356\" data-end=\"1371\">Oncotarget, 7<\/em>(37), 58405\u201358417.<\/span><\/li>\n<li data-start=\"1393\" data-end=\"1530\"><span style=\"font-size: 10pt;\">Lima, T. N., &amp; Pedriali Moraes, C. A. (2018). Bioakt\u00edvne peptidy: Aplik\u00e1cie a v\u00fdznam pre kozmeceutik\u00e1. <em data-start=\"1506\" data-end=\"1520\">Kozmetika, 5<\/em>(2), 21.<\/span><\/li>\n<li data-start=\"1532\" data-end=\"1743\"><span style=\"font-size: 10pt;\">Pickart, L., Vasquez-Soltero, J. M., &amp; Margolina, A. (2015). GHK-Cu m\u00f4\u017ee predch\u00e1dza\u0165 oxida\u010dn\u00e9mu stresu v poko\u017eke regul\u00e1ciou medi a modifik\u00e1ciou expresie mnoh\u00fdch antioxida\u010dn\u00fdch g\u00e9nov. <em data-start=\"1714\" data-end=\"1728\">Kozmetika, 2<\/em>(3), 236\u2013247.<\/span><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Hl\u00e1sen\u00e9 ved\u013eaj\u0161ie \u00fa\u010dinky meden\u00e9ho peptidu (GHK-Cu) v sa v vedeck\u00fdch \u0161t\u00fadi\u00e1ch zvy\u010dajne minim\u00e1lne a naj\u010dastej\u0161ie sa obmedzuj\u00fa na mierne lok\u00e1lne reakcie. V \u0161t\u00fadi\u00e1ch na \u013eu\u010foch sa v...<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[93],"tags":[],"class_list":["post-46058","post","type-post","status-publish","format-standard","hentry","category-kategoria-ghk-cu","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/posts\/46058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/comments?post=46058"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/posts\/46058\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/media?parent=46058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/categories?post=46058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/tags?post=46058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}